2m 2m 2m 2m 2m 2m 2m
FULCRUM THERA (FULC)
NASDAQ
$3.69-$0.02 (-0.41%)
Price as of Oct 22, 2026 7:30 PM EDT- $282.6MMarket Cap
- -59.07%1-Year Change
- BiotechnologyIndustry
FULCRUM THERA (FULC)
$3.69-$0.02 (-0.41%)
FULC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.70 | ||
Change | -$0.02 (-0.54%) | ||
Open | $3.72 | ||
High | $3.75 | ||
Low | $3.70 | ||
Previous Close | $3.72 | ||
Volume | 923,470 | ||
30-Day Average Volume | 1,403,902 | ||
1-Week Change | 0.82% | ||
1-Month Change | -2.63% | ||
1-Year Change | -59.07% | ||
3-Year Change | 1.65% | ||
5-Year Change | -84.84% | ||
Fundamentals | |||
Shares Outstanding | 76.4M | ||
Total Assets | $324.0M | ||
Market Cap | $282.6M | ||
Enterprise Value | $234.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$26.2M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$26.2M | ||
EBITDA | -$26.0M | ||
Net Working Capital | $312.6M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue